Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/04/2014EP2737896A2 umirolimus encapsulated in a liposome or a micelle for the treating cancer
06/04/2014EP2737809A1 Beverage containing amino acids, suitable for use in the prevention and treatment of mental disorders
06/04/2014EP2737804A1 Processes for the preparation of phospholipid-enriched dairy products as neutraceuticals for the formulation of functional foods, and neutraceutical and/or pharmaceutical compositions thereof
06/04/2014EP2737062A2 Near-infrared light-activated proteins
06/04/2014EP2736919A2 NOVEL 17ß-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS
06/04/2014EP2736918A1 Progesterone antagonists
06/04/2014EP2736915A1 New crystalline forms of tulathromycin
06/04/2014EP2736910A1 Pyrazoline derivatives and their use as selective androgen receptor modulators
06/04/2014EP2736908A1 Bicyclic pyrimidone compounds
06/04/2014EP2736907A1 Indazoles
06/04/2014EP2736906A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
06/04/2014EP2736904A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
06/04/2014EP2736903A1 Aryl naphthalide lignans as anti-hiv agents
06/04/2014EP2736902A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
06/04/2014EP2736901A1 Heterocyclyl pyrimidine analogues as jak inhibitors
06/04/2014EP2736900A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands
06/04/2014EP2736899A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands
06/04/2014EP2736898A1 5ht1a antagonist useful for in vivo imaging
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736895A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
06/04/2014EP2736893A1 Thiophene compounds
06/04/2014EP2736892A1 Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof
06/04/2014EP2736891A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals
06/04/2014EP2736890A1 Cysteine prodrugs
06/04/2014EP2736888A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
06/04/2014EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof
06/04/2014EP2736886A1 Substituted quinolines and their use as medicaments
06/04/2014EP2736885A2 Cysteinyl leukotriene antagonists
06/04/2014EP2736883A1 Nuclear transport modulators and uses thereof
06/04/2014EP2736882A1 Substituted heterocyclic aza derivatives
06/04/2014EP2736880A1 N,n-dialkylalkylenyl esters, compositions thereof, and methods for use thereof
06/04/2014EP2736876A1 Novel ceramide analogues, processes for preparing same and uses thereof
06/04/2014EP2736531A2 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
06/04/2014EP2736520A2 Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs)
06/04/2014EP2736518A2 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
06/04/2014EP2736517A2 Pharmaceutical composition for treating atopic dermatitis
06/04/2014EP2736516A1 Sumoylation of serca2a and cardiovascular disease
06/04/2014EP2736515A2 17-hydroxyprogesterone ester-containing oral compositions and related methods
06/04/2014EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/04/2014EP2736513A1 Pharmaceutical composition comprising a trpa1 antagonist and a steroid
06/04/2014EP2736512A1 Methods and compositions for treatment of epithelial wounds
06/04/2014EP2736511A1 Animal ectoparasite-controlling agent and method for preventing or treating infection in animals caused by parasites by using the controlling agent
06/04/2014EP2736510A2 Methylphenidate-prodrugs, processes of making and using the same
06/04/2014EP2736509A1 Process for preparing prasugrel
06/04/2014EP2736508A1 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
06/04/2014EP2736507A1 Basic alpha lipoic acid solution and its uses
06/04/2014EP2736506A2 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer
06/04/2014EP2736505A1 3-hydroxyanthranilic acid (3-haa) therapy for prevention and treatment of hyperlipidemia and its cardiovascular complications
06/04/2014EP2736504A1 Sandalwood oil and its uses related to skin disorders
06/04/2014EP2736503A1 Levomilnacipran drug for functional rehabilitation after an acute neurological stroke
06/04/2014EP2736502A1 Method for increasing the intraocular pressure in an animal
06/04/2014EP2736501A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
06/04/2014EP2736500A1 Use of tmprss2 inhibitors as medicaments
06/04/2014EP2736499A1 Sustained release tablet comprising pregabalin through two-phase release-controlling system
06/04/2014EP2736498A1 Prolonged release pharmaceutical composition comprising galantamine and method for the preparation thereof
06/04/2014EP2736497A1 Tamper-resistant tablet providing immediate drug release
06/04/2014EP2736496A1 Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
06/04/2014EP2736495A1 Tamper-resistant tablet providing immediate drug release
06/04/2014EP2736494A1 Compressed solid pharmaceutical composition comprising amorphous particulate valsartan as the active ingredient
06/04/2014EP2736491A2 Bepotastine compositions
06/04/2014EP2736485A1 Aqueous solutions of lipophilic substances, in particular medicinal solutions
06/04/2014EP2736480A1 Delivery of an active material
06/04/2014EP2736354A1 Use of citrulline and combination compound for improving male fertility
06/04/2014EP2736338A1 FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS
06/04/2014EP2736336A1 Treatment of multiple sclerosis with combination of laquinimod and interferon-beta
06/04/2014EP2736335A1 Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate
06/04/2014EP2736332A1 Compounds and methods
06/04/2014EP2736330A1 Compounds and methods
06/04/2014EP2736329A1 Compounds and methods
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103842386A Method and apparatus for the production of an arabinoxylan-enriched preparation and other co-products
06/04/2014CN103842370A Progesterone antagonists
06/04/2014CN103842369A Compounds and pharmaceutical compositions for the treatment of viral infections
06/04/2014CN103842365A Cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
06/04/2014CN103842364A Anti-viral compounds
06/04/2014CN103842363A Substituted imidazopyridines and the use thereof
06/04/2014CN103842362A Compositions and methods for treating Alzheimer's disease
06/04/2014CN103842360A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
06/04/2014CN103842359A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
06/04/2014CN103842357A Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103842353A Pyridines compounds as inhibitors of kinase
06/04/2014CN103842348A Selective androgen receptor modulators
06/04/2014CN103842344A Cystelinyl leukotriene antagonists based on quinolin, quinoxaline or benz[c]thiazole
06/04/2014CN103842343A A crystalline form of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
06/04/2014CN103842340A Nuclear transport modulators and uses thereof
06/04/2014CN103842337A Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
06/04/2014CN103842332A Cyclopropaneamine compound
06/04/2014CN103842330A Choline salt of an anti - inflammatory substituted cyclobutenedione compound
06/04/2014CN103841991A Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
06/04/2014CN103841988A Lixisenatide and metformin for treatment of diabetes type 2
06/04/2014CN103841987A Treatment of degenerative joint disease
06/04/2014CN103841985A Agent for improving quality of sleep
06/04/2014CN103841984A Method for preparing an adsorbed drone brood and the composition thereof
06/04/2014CN103841979A Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
06/04/2014CN103841978A immunologically modified carbon nanotubes for cancer treatment
06/04/2014CN103841977A Composition containing s-adenosyl-l-methionine with excellent storage stability
06/04/2014CN103841976A Combinations of AKT AND MEK inhibitor compounds, and methods of use
06/04/2014CN103841975A Combinations of akt inhibitor compounds and vemurafenib, and methods of use
06/04/2014CN103841974A Treatment of rhinitis
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 7860